This opportunity is no longer accepting applications.
grant PAR-22-086

Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)

This grant opportunity seeks applications to study how bacteria, bacteriophages, and other non-cancer-causing viruses interact with tumors and the immune system, with the goal of advancing cancer imaging, treatment, and diagnostics. The focus is on using these microorganisms in various roles, such as anti-tumor agents, immune activators, or treatment and imaging delivery vehicles, complementin…

This Funding Opportunity Announcement (FOA) solicits grant applications proposing to utilize bacteria, archaebacteria, bacteriophages, or other non-oncolytic viruses and their natural products to study the underlying mechanisms of the complex interactions between microorganisms, tumors, and the …

Funding Source

Agency: National Institutes of Health
Program: SBIR

Awards & funding

Award Ceiling: $200,000
Award Amount: $200,000

Dates

Opportunity Released: February 18, 2022
Open for Submission: February 18, 2022
Submission Deadline: May 7, 2025
Application Window Closes: May 7, 2025

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.